Stockscreener 앱 받기
14.10
2.96%
-0.43
시간 외 거래:
14.11
0.010
+0.07%
Erasca Inc 주식(ERAS)의 최신 뉴스
Erasca (NASDAQ:ERAS) Hits New 1-Year HighShould You Buy? - MarketBeat
Erasca, Inc. (ERAS): A Bull Case Theory - Yahoo Finance
Erasca Conference: ERAS Teases 2026 Catalysts for Pan-RAS ERAS-0015 and Pan-KRAS ERAS-4001 - Yahoo Finance
ERAS: Lead RAS-targeted therapies show strong early data, with major trial updates expected in 2024 - TradingView
ERAS: Lead RAS-targeted therapies show promising early results, with key clinical updates expected in 2024 - TradingView
Erasca, Inc. (ERAS) Stock Analysis: Unlocking Potential in Precision Oncology with a Robust Pipeline - DirectorsTalk Interviews
Erasca Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Erasca (NASDAQ:ERAS) Hits New 12-Month HighHere's What Happened - MarketBeat
Erasca stock hits 52-week high at $13.30 - Investing.com
Erasca Granted US Patent for Investigational Drug ERAS-4001 to Treat Solid Tumors - marketscreener.com
Erasca Announces Issuance of a U.S. Patent Covering Pan-KRAS Inhibitor ERAS-4001 - Bitget
New Erasca patent protects ERAS-4001 for RAS-driven cancers to 2043 - Stock Titan
Will Erasca Inc. outperform small cap indexes2025 Pullback Review & AI Optimized Trading Strategy Guides - mfd.ru
Setup Watch: How does Erasca Inc perform in inflationary periods2025 Major Catalysts & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Erasca, Inc. (NASDAQ:ERAS) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Erasca (NASDAQ:ERAS) Sets New 12-Month HighShould You Buy? - MarketBeat
Registration Momentum Builds Across the Oncology Pipeline - The Globe and Mail
ERAS PE Ratio & Valuation, Is ERAS Overvalued - Intellectia AI
Can Erasca Inc. stock deliver consistent earnings growthJuly 2025 Retail & Free Technical Pattern Based Buy Signals - mfd.ru
Assessing Erasca (ERAS) Valuation After Early Clinical Signals And Strong Share Price Momentum - Sahm
Can Erasca Inc. stock beat market expectations this quarter2025 Volume Leaders & Daily Profit Maximizing Trade Tips - mfd.ru
ERAS Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Erasca Touts Early ERAS-0015 Responses, Potency Edge in Guggenheim Fireside Chat - MarketBeat
Erasca stock today: ERAS rises as traders parse Guggenheim biotech talk, eye next data - Bez Kabli
Will Erasca Inc. be affected by tariffsJuly 2025 Volume & Verified Stock Trade Ideas - mfd.ru
Erasca stock reaches 52-week high at 12.48 USD By Investing.com - Investing.com South Africa
Erasca (NASDAQ:ERAS) Trading Up 6.8%Should You Buy? - MarketBeat
Erasca stock reaches 52-week high at 12.48 USD - Investing.com
ERAS: Early clinical data show promising efficacy and safety for next-generation pan-RAS and pan-KRAS inhibitors - TradingView
What analysts say about Erasca Inc. stockInsider Selling & Free Growth Oriented Trading Recommendations - mfd.ru
Will Erasca Inc. stock go up in YEARTrade Risk Report & Proven Capital Preservation Tips - mfd.ru
Erasca Sees Unusually High Options Volume (NASDAQ:ERAS) - MarketBeat
What sentiment indicators say about Erasca Inc. stock2025 Growth vs Value & Weekly Breakout Watchlists - mfd.ru
Stifel reiterates Buy rating on Erasca stock, maintains $10 price target - Investing.com Australia
Erasca (NASDAQ:ERAS) Sets New 1-Year HighStill a Buy? - MarketBeat
Stifel reiterates Buy rating on Erasca stock, maintains $10 price target By Investing.com - Investing.com South Africa
Erasca (ERAS) Hits Fresh High Anew as Firm Gets up to 267% PT Hike - MSN
Erasca (ERAS) Is Up 15.2% After Upsized Offering Extends Cash Runway For RAS/MAPK Pipeline - simplywall.st
Erasca (NASDAQ:ERAS) Trading 6.4% HigherHere's What Happened - MarketBeat
Erasca to Present at Upcoming Conferences in February - The Manila Times
Erasca (ERAS) Price Target Increased by 60.94% to 10.51 - Nasdaq
Erasca (ERAS) Is Up 10.4% After $225M Follow-On Offering And RAS Pipeline UpdatesHas The Bull Case Changed? - Yahoo Finance
Erasca (NASDAQ:ERAS) Hits New 52-Week HighStill a Buy? - MarketBeat
Erasca stock hits 52-week high at $10.71 By Investing.com - Investing.com Nigeria
Erasca stock hits 52-week high at $10.71 - Investing.com India
Up 460% in the Past Year, Should You Take a Gamble on This Speculative Stock? - Barchart.com
Palmetto Grain Brokerage - Palmetto Grain Brokerage
Mizuho initiates Erasca (ERAS) with 'outperform' rating and $16 PT - MSN
Mizuho Initiates Erasca (ERAS) With 'Outperform' Rating and $16 PT - Finviz
5.71%
0.02%
자본화:
|
볼륨(24시간):